QNDPF yields 5.59% · MRK yields 2.76%● Live data
📍 QNDPF pulled ahead of the other in Year 1
Combined, QNDPF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of QNDPF + MRK for your $10,000?
Qingdao Port International Co., Ltd. operates the Port of Qingdao. It operates through six segments: Container Handling and Ancillary Services; Metal Ores, Coal and Other Cargo Handling and Ancillary Services; Liquid Bulk Handling and Ancillary Services; Logistics and Port Value-Added Services; Port Ancillary Services; and Financial Services. The company is involved in the loading and discharging of containers, metal ores, coal, grains, and break bulk and liquid bulk cargos, as well as other general cargos. It also provides storage services; and port management, container freight station, cargo logistics, agency, towing, tallying, facilities construction, and other services. In addition, the company manufactures port related equipment; and supplies electricity power, fuel, and other products. Further, it offers port machinery manufacture, construction, tugboat and barging, and ocean shipping tallying services; and security, emergency, stevedoring and handling, and textile and apparel services. Additionally, the company provides financial products and services comprising deposit taking, guarantee, insurance agency, and investment and financial management services, as well as corporate loans; and shipping repair and agency, engineering and construction, cargo and trade agency, engineering design, technology, property management, media, lightering, oil pipeline transportation, and check and inspection services. It also engages in the LNG operations. As of December 31, 2021, it operated 92 berths at the Port of Qingdao. The company was incorporated in 2013 and is headquartered in Qingdao, the People's Republic of China. Qingdao Port International Co., Ltd. operates as a subsidiary of Shandong Qingdao Port Group Co., Ltd.
Full QNDPF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.